Skip to main content
NUTX
NASDAQ Trade & Services

Appeals Court Strikes Down 'Ghost Rates' in No Surprises Act, Potentially Boosting Nutex Reimbursements

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$186.81
Mkt Cap
$1.279B
52W Low
$77.21
52W High
$204
52W Position info
142% above low
Off High info
8.4% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

NUTX has more than doubled off its 52-week low of $77.21.

Summary

A federal appeals court struck down rules that artificially lowered reimbursement rates for out-of-network care, a decision that could improve Nutex Health's revenue from No Surprises Act arbitrations.


Key Events · Legal and Risk Events · NUTX

  • Court Vacates 'Ghost Rate' Rule

    The Fifth Circuit en banc vacated the July 2021 interim final rule that allowed insurers to include non-negotiated placeholder rates in QPA calculations, which artificially suppressed reimbursement amounts.

  • Bonus Payments Must Be Included

    The court ruled that insurers must include bonus and incentive payments in QPA calculations, reversing the prior exclusion that deflated the QPA.

  • Impact on Nutex Reimbursements

    As a healthcare provider negotiating under the No Surprises Act, Nutex could see higher QPAs in future arbitrations, potentially increasing out-of-network revenue. The court noted that under the old rule, IDR results exceeded QPA in 85% of cases.

  • Regulatory Transition Period

    The Departments are directed to exercise enforcement discretion, allowing insurers to continue using existing QPAs until new rules are promulgated, so the financial impact is not immediate.


Analysis · NUTX · Trade & Services

The Fifth Circuit's en banc ruling vacates the July 2021 rule that allowed insurers to suppress Qualifying Payment Amounts (QPAs) by including non-negotiated 'ghost rates' and excluding bonus payments. For Nutex Health, whose revenue depends on out-of-network reimbursement negotiations under the No Surprises Act, this decision could raise the baseline QPA used in arbitration, improving the company's negotiating position and potentially increasing future revenue. The court noted that under the old rule, IDR arbitration results exceeded the QPA in 85% of cases, indicating systematic underpayment. While the Departments must issue new rules, the immediate effect is that insurers may continue using existing QPAs until recalculated, so the financial impact is not yet realized.

At the time of this filing, NUTX was trading at $186.81 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $77.21 to $204.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NUTX - Latest Insights

NUTX
Aug 06, 2026, 4:48 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $165.00
Real-time Price: $186.81 info
Change: +$21.81 (+13%) info
Market Cap: $1.279B info
NUTX
Apr 30, 2026, 4:11 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $121.80
Real-time Price: $186.81 info
Change: +$65.01 (+53%) info
Market Cap: $1.279B info
NUTX
Apr 30, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $121.80
Real-time Price: $186.81 info
Change: +$65.01 (+53%) info
Market Cap: $1.279B info
NUTX
Apr 30, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $121.80
Real-time Price: $186.81 info
Change: +$65.01 (+53%) info
Market Cap: $1.279B info
NUTX
Mar 13, 2026, 4:01 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $88.80
Real-time Price: $186.81 info
Change: +$98.01 (+110%) info
Market Cap: $1.279B info